Outcomes and inflammation changes in different types of immunocompromised patients with critically ill COVID-19 admitted to ICU: a national multicenter study

Chunyan Li,Hangyong He,Yuqiong Wang,Linna Huang,Ziying Chen,Qi Zhang,Ying Cai,Tianshu Zhai,Xiaojing Wu,Qingyuan Zhan
DOI: https://doi.org/10.1186/s12890-024-03362-6
IF: 3.1
2024-11-02
BMC Pulmonary Medicine
Abstract:Immunocompromised patients face higher risks of Severe Acute Respiratory Syndrome Coronavirus 2 infection and co-infections, leading to a possibility of high disease severity and poor outcomes. Conversely, immunosuppression can mitigate the excessive inflammatory response induced by the virus, potentially reducing disease severity. This study aims to investigate the prognostic differences and early inflammatory response characteristics in various types of immunocompromised patients with severe coronavirus disease 2019 (COVID-19) admitted to intensive care unit (ICU), summarize their clinical features, and explore potential mechanisms.
respiratory system
What problem does this paper attempt to address?